Compounds > hydroxycodeinone
Page last updated: 2024-09-27

hydroxycodeinone

Description

hydroxycodeinone: RN given refers to (5alpha)-isomer; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9926820
SCHEMBL ID38000
MeSH IDM0051513

Synonyms (22)

Synonym
508-54-3
unii-91138f771g
91138f771g ,
codeinone, 14-hydroxy-
morphinan-6-one, 7,8-didehydro-4,5-epoxy-14-hydroxy-3-methoxy-17-methyl-, (5-alpha)-
brn 4552573
einecs 208-085-8
hydroxycodeinone
(5alpha)-7,8-didehydro-4,5-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one
14-hydroxy codeinone
codeine monohydrate impurity k [ep impurity]
hydroxycodeinone [mi]
morphinan-6-one, 7,8-didehydro-4,5-epoxy-14-hydroxy-3-methoxy-17-methyl-, (5-.alpha.)-
codeine hydrochloride dihydrate impurity k [ep impurity]
codeine phosphate hemihydrate impurity k [ep impurity]
14.beta.-hydroxycodeinone
oxycodone hydrochloride impurity d [ep impurity]
(5.alpha.)-7,8-didehydro-4,5-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one
SCHEMBL38000
7,8-didehydro-4,5alpha-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one (14-hydroxycodeinone)
Q27271360
DTXSID801316557

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (33.33)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceDescriptionRelationhip StrengthStudiesTrialsClassesRoles
hempa[no description available]medium10phosphoramideinsect sterilant;
mutagen
chlorambucil[no description available]medium10aromatic amine;
monocarboxylic acid;
nitrogen mustard;
organochlorine compound;
tertiary amino compound		alkylating agent;
antineoplastic agent;
carcinogenic agent;
drug allergen;
immunosuppressive agent
oxycodone[no description available]medium60organic heteropentacyclic compound;
semisynthetic derivative		antitussive;
mu-opioid receptor agonist;
opioid analgesic
mitomycin[no description available]medium10mitomycinalkylating agent;
antineoplastic agent
hydrocodone[no description available]medium10morphinane-like compound;
organic heteropentacyclic compound		antitussive;
mu-opioid receptor agonist;
opioid analgesic
codeine[no description available]medium40morphinane alkaloid;
organic heteropentacyclic compound		antitussive;
drug allergen;
environmental contaminant;
opioid analgesic;
opioid receptor agonist;
prodrug;
xenobiotic
morphine[no description available]medium10morphinane alkaloid;
organic heteropentacyclic compound;
tertiary amino compound		anaesthetic;
drug allergen;
environmental contaminant;
geroprotector;
mu-opioid receptor agonist;
opioid analgesic;
plant metabolite;
vasodilator agent;
xenobiotic
6-codeinone[no description available]medium10isoquinoline alkaloid
singlet oxygen[no description available]medium10chalcogen;
monoatomic oxygen;
nonmetal atom		macronutrient
mercury[no description available]medium10elemental mercury;
zinc group element atom		neurotoxin
thebaine[no description available]medium10morphinane alkaloid;
organic heteropentacyclic compound
benzofurans[no description available]medium10
ConditionIndicatedRelationship StrengthStudiesTrials
Absence Seizure0low10
Absence Seizures0low10
Acute Hypercapnic Respiratory Failure0low10
Acute Hypoxemic Respiratory Failure0low10
Anesthesia0low10
Atonic Absence Seizure0low10
Atonic Absence Seizures0low10
Atonic Seizure0low10
Atonic Seizures0low10
Clonic Seizure0low10
Clonic Seizures0low10
Complex Partial Seizure0low10
Complex Partial Seizures0low10
Convulsion0low10
Convulsion, Non-Epileptic0low10
Convulsions0low10
Convulsive Seizure0low10
Convulsive Seizures0low10
Epileptic Seizure0low10
Epileptic Seizures0low10
Generalized Absence Seizure0low10
Generalized Absence Seizures0low10
Generalized Tonic-Clonic Seizures0low10
Hypercapnic Acute Respiratory Failure0low10
Hypercapnic Respiratory Failure0low10
Hypoxemic Acute Respiratory Failure0low10
Hypoxemic Respiratory Failure0low10
Jacksonian Seizure0low10
Myoclonic Seizure0low10
Myoclonic Seizures0low10
Non-Epileptic Seizure0low10
Non-Epileptic Seizures0low10
Nonepileptic Seizure0low10
Nonepileptic Seizures0low10
Partial Seizure0low10
Partial Seizures0low10
Petit Mal Convulsion0low10
Respiratory Depression0low10
Respiratory Failure0low10
Respiratory Insufficiency0low10
Seizure0low10
Seizures0low10
Seizures, Auditory0low10
Seizures, Clonic0low10
Seizures, Convulsive0low10
Seizures, Epileptic0low10
Seizures, Focal0low10
Seizures, Generalized0low10
Seizures, Gustatory0low10
Seizures, Motor0low10
Seizures, Olfactory0low10
Seizures, Sensory0low10
Seizures, Somatosensory0low10
Seizures, Tonic0low10
Seizures, Tonic-Clonic0low10
Seizures, Vertiginous0low10
Seizures, Vestibular0low10
Seizures, Visual0low10
Single Seizure0low10
Tonic Clonic Seizure0low10
Tonic Seizure0low10
Tonic Seizures0low10
Tonic-Clonic Seizure0low10
Tonic-Clonic Seizures0low10
Ventilatory Depression0low10

Research Highlights

Dosage (1)

ArticleYear
Determination of 6-oxo-morphinans, as the oximes, by difference circular dichroism spectroscopy.
Analytical and bioanalytical chemistry, Volume: 374, Issue: 3		2002
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]